NationalICMR Distances Itself From BHU's 'Poorly Designed' Study On Covaxin Side EffectsBY Asmita Ravi Shankar
NationalAfter Covishield, Now Covaxin Hits Headlines Over 'Health Issues' In 30% Of Those JabbedBY Outlook News Desk
NationalBharat Biotech Highlights Covaxin's 'Safety First' Feature Amid AstraZeneca's Covishield Row Over Side EffectsBY Outlook News Desk
NationalBharat Biotech Recalls Batch Of Typhoid Vaccines After Being Flagged Over Quality IssuesBY Outlook News Desk
Art & EntertainmentManoj Bajpayee To Narrate 'The Vial', Documentary On India's Covid Vax SuccessBY IANS
National3 Lakh Doses Of Intranasal Covid Vaccine Sent To Hospitals: Bharat Biotech's Krishna EllaBY PTI
NationalBharat Biotech's Intranasal COVID-19 Vaccine To Cost Rs 800 For Private And Rs 325 For Govt SuppliesBY PTI
NationalNasal Vaccine Against Covid-19 To Be Available On CoWIN: All You Need To KnowBY Outlook News Desk
NationalGovernment Not Liable For Vaccine-Related Deaths: Centre To Supreme CourtBY Outlook News Desk
NationalRoutine Immunisation Suffered Due To Covid-19, It Has To Be Put Back On Track: MandaviyaBY PTI
InternationalUSA: Florida's Top Health Official Advises Against Covid mRNA Vaccines, Cites High Risk Of Heart Side EffectsBY Outlook News Desk
NationalBharat Biotech's Covid Nasal Vaccine Gets Nod For Emergency Use: All You Need To KnowBY Outlook News Desk
NationalNTAGI Panel Recommends Use Of Covid-19 Vaccines Corbevax, Covaxin For Children Aged 5-12 YearsBY Outlook News Desk
NationalBharat Biotech Must Address WHO's Covaxin Suspension To Avoid EUL Cancellation, Says MEABY Outlook News Desk
NationalCovid Vaccine Covaxin Cleared For 6-12 Age Group By Drugs Regulator DCGI: ReportsBY Outlook News Desk
NationalSII To Give Free Covishield Vials To Pvt Vaccination Centres To Compensate For Price DifferenceBY Outlook News Desk
NationalCOVID Vaccine Precaution Dose: Serum Institute, Bharat Biotech Cut Prices To Rs 225BY Outlook News Desk
NationalCovaxin Booster Enhances Antibody Response Against COVID-19 Variants Including Omicron: StudyBY Outlook News Desk
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
